サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1735620

ワクチン送達デバイスの世界市場規模：デバイス別、投与経路別、エンドユーザー別、地域範囲別および予測

Global Vaccine Delivery Devices Market Size By Devices, By Route Of Administration, By End-User, By Geographic Scope And Forecast

出版日
ページ情報
英文 202 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.76円
ワクチン送達デバイスの世界市場規模：デバイス別、投与経路別、エンドユーザー別、地域範囲別および予測
出版日: 2025年05月02日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ワクチン送達デバイスの市場規模と予測

ワクチン送達デバイス市場規模は、2024年に49億9,000万米ドルと評価され、2026年から2032年にかけてCAGR 8.5%で成長し、2032年には88億3,000万米ドルに達すると予測されています。

  • ワクチン送達デバイスは、ワクチン投与のために特別に設計されたツールや技術です。これらの機器は、正確な投与、安全な送達、感染症に対する適切な予防接種を確実にするために、ヘルスケア専門家や個人にとって不可欠です。
  • ワクチン送達デバイスは、小児ワクチン接種スケジュール、季節性インフルエンザワクチン接種キャンペーン、その他の予防医療イニシアチブを含む定期的な予防接種プログラムのために、病院、診療所、医院などのヘルスケア施設で一般的に使用されています。
  • 特に、ヘルスケア・サービスへのアクセスが制限されている農村部や十分なサービスを受けていない地域では、ワクチン送達装置は地域保健プログラムやアウトリーチ活動において重要な役割を果たしています。
  • 最新のワクチン送達技術のひとつである無針注射は、集団予防接種プログラムで効果的に使用されています。これは、針刺し傷害や、1本の針を何度も使用することに伴う合併症の可能性を減らすのに役立ちます。
  • さらに、その他のワクチン送達装置には、ジェット注射器、使い捨て注射器、マイクロニードル、皮内送達装置などがあります。これらはすべて不活化ポリオウイルスワクチンの送達に使用されます。

ワクチン送達デバイスの世界市場力学

ワクチン送達デバイス市場を形成している主な市場力学は以下の通り：

主な市場促進要因

  • 強力な研究開発：世界の製品供給の増加は、風土病撲滅を目的としたワクチン接種プログラムの市場拡大を促進しています。政府、病院、製薬企業は、定期的かつ安価なワクチン接種を推進しており、政府の積極的な監視により、すべての人が最小限の費用でワクチン接種を受けられるようになっています。
  • ヘルスケア分野における予防接種範囲の拡大：ワクチン送達装置の需要は、予防接種の対象範囲を拡大し、十分なサービスを受けていない人々への普及を目指す取り組みによって牽引されており、政府、医療機関、NGOが協力して、中低所得国における予防接種率の向上を目指しています。
  • 政府によるヘルスケア支出の増加：ワクチン送達デバイスの需要は、予防接種率を向上させ、十分なサービスを受けていない人々にワクチンを供給するための政府主導の取り組みによって促進され、医療機関とNGOの協力によって促進されています。
  • 技術の進歩：針刺し傷害、汚染された針による感染症、不適切に滅菌された針による血液媒介感染症などのリスクがあるため、針を使用しない送達装置の需要が急増しています。市場成長の原動力となるのは、新規デリバリー技術に対する主要企業、国際機関、研究機関の関心です。
  • 例えば、2022年1月、ファイザー社とAcuitas Therapeutics社は、mRNAワクチンおよび治療薬用に特別に設計された脂質ナノ粒子送達システムの開発で提携しました。この提携は、両社の専門知識を活用してmRNAベースの治療やワクチンの送達効率と有効性を高めることを目的としています。

主な課題

  • ワクチン投与コストの高さ：慢性疾患や感染症の罹患率の増加が市場成長の原動力となっています。しかし、ワクチン1回投与量に関連するコストが高いことが市場拡大の妨げとなっています。国際機関は世界中に数百万回分のワクチンを供給しているが、コストが高いため、まだ多くの地域でワクチン接種が行われていないです。
  • インフラの課題：ワクチンのサプライチェーンでは、効力を維持するために厳格な温度管理が必要です。農村部や遠隔地など、コールドチェーンのインフラが不十分な地域では、これが困難となり、ワクチンの有効性が損なわれ、ワクチン供給装置の需要が減少する可能性があります。
  • ヘルスケア人材の能力課題：訓練されたヘルスケア従事者の不足は、ワクチンの適切な投与に支障をきたし、投与遅延、投与ミス、送達装置の不適切な取り扱いを招き、適切な送達装置があったとしても、予防接種の結果全体に影響を及ぼします。
  • ワクチンのサプライチェーンにおける混乱：製造の遅延、流通のボトルネック、物流の課題など、サプライチェーンの混乱は、ワクチン供給装置の入手可能性や入手しやすさに影響を与える可能性が高いです。自然災害、地政学的緊張、公衆衛生上の緊急事態などによるサプライチェーンの混乱は、予防接種プログラムを混乱させ、ワクチン送達装置の配備を制限する可能性があります。

主な動向：

  • 無痛投与：患者の快適性と受容性を高めるため、痛みを伴わないワクチン投与法の開発への関心が高まっています。マイクロニードルパッチなどの技術は、痛みの少ない低侵襲な皮膚穿刺によってワクチンを送達するもので、特に小児や老年層に対しては、従来の注射針を用いた方法よりも利点がある可能性があります。
  • スマート注射器：センサーや接続機能を備えたスマート注射器など、ワクチン送達デバイスにデジタルヘルス技術を統合することで、ワクチン投与のリアルタイムモニタリング、投与量の追跡、ワクチン接種スケジュールの遵守が可能になります。これらの機器は、データ収集を容易にし、患者関与を強化し、遠隔患者モニタリングをサポートします。
  • 生分解性で環境に優しい素材：持続可能性と環境への責任を重視する傾向が強まっていることから、ワクチン送達装置には生分解性で環境に優しい素材が採用されています。製造業者は、環境への影響を低減し、循環経済の原則を推進するため、バイオプラスチックや堆肥化可能な材料など、従来のプラスチックに代わる材料を模索しています。

目次

第1章 世界のワクチン送達デバイス市場の導入

  • 市場イントロダクション
  • 調査範囲
  • 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

  • データマイニング
  • バリデーション
  • 一次資料
  • データソース一覧

第4章 ワクチン送達デバイスの世界市場展望

  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • ポーターのファイブフォースモデル
  • バリューチェーン分析

第5章 ワクチン送達デバイスの世界市場：デバイス別

  • 概要
  • 注射器
  • ジェットインジェクター

第6章 ワクチン送達デバイスの世界市場：投与経路別

  • 概要
  • 皮内接種
  • 筋肉内ワクチン接種
  • 皮下ワクチン接種

第7章 ワクチン送達デバイスの世界市場：エンドユーザー別

  • 概要
  • 病院・診療所
  • 在宅医療
  • 外来手術センター

第8章 ワクチン送達デバイスの世界市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他の欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他のアジア太平洋
  • 世界のその他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第9章 世界のワクチン送達デバイス市場の競合情勢

  • 概要
  • 各社の市場ランキング
  • 主な開発戦略

第10章 企業プロファイル

  • 3M
  • Becton Dickinson & Company
  • Gerresheimer AG
  • Bioject Medical Technologies, Inc.（Inovio Pharmaceutical Inc.）
  • SCHOTT AG
  • Valeritas
  • PharmaJet
  • Vaxxas
  • Corium International, Inc

第11章 付録

  • 関連調査
目次
Product Code: 35588

Vaccine Delivery Devices Market Size And Forecast

Vaccine Delivery Devices Market size was valued at USD 4.99 Billion in 2024 and is projected to reach USD 8.83 Billion by 2032, growing at a CAGR of 8.5% from 2026-2032.

  • Vaccine delivery devices are tools and technologies specifically designed for the administration of vaccines. These devices are essential for healthcare professionals and individuals to ensure accurate dosage, safe delivery, and proper immunization against infectious diseases.
  • Vaccine delivery devices are commonly used in healthcare facilities such as hospitals, clinics, and medical offices for routine immunization programs, including childhood vaccination schedules, seasonal flu vaccination campaigns, and other preventive healthcare initiatives.
  • Vaccine delivery devices play a crucial role in community health programs and outreach efforts, particularly in rural or underserved areas where access to healthcare services may be limited.
  • One of the latest vaccine delivery technologies, such as needle-free options, is effectively used in mass immunization programs. It helps to reduce the chances of needle stick injuries and the complications associated with the multiple uses of a single needle.
  • Moreover, other vaccine delivery devices include jet injectors, disposable syringes, microneedles, and intradermal delivery devices. These are all used for the delivery of inactivated poliovirus vaccines.

Global Vaccine Delivery Devices Market Dynamics

The key market dynamics that are shaping the Vaccine Delivery Devices Market include:

Key Market Drivers:

  • Robust Research and Development: The global increase in product supply is facilitating market expansion for vaccination programs aimed at eradicating endemic diseases. Governments, hospitals, and pharmaceutical corporations are promoting routine and affordable vaccinations, with active government surveillance ensuring everyone receives them at minimal cost.
  • Expanded Immunization Coverage in Healthcare Sector: The demand for vaccine delivery devices is driven by efforts to expand immunization coverage and reach underserved populations, with collaboration between governments, healthcare organizations, and NGOs aiming to improve vaccination rates in low- and middle-income countries.
  • Rising Healthcare Expenditure by Government: The demand for vaccine delivery devices is fueled by government-led initiatives to enhance immunization coverage and reach underserved populations, facilitated by collaborations between healthcare organizations and NGOs.
  • Technological Advancements: The demand for needle-free delivery is surging due to the risks of needle stick injuries, infection from contaminated needles, and blood-borne infections from improperly sterilized needles. The market growth is expected to be driven by interest from key players, international organizations, and institutions in novel delivery technologies.
  • For instance, in January 2022, Pfizer Inc. and Acuitas Therapeutics joined forces to develop a lipid nanoparticle delivery system that is specifically designed for mRNA vaccines and therapeutics. This collaboration aims to leverage the expertise of both companies to enhance the delivery efficiency and effectiveness of mRNA-based treatments and vaccines.

Key Challenges:

  • High Costs of Vaccine Dose: The growing incidence of chronic and infectious diseases is driving market growth. However, high costs associated with the per-dose vaccine volume are hampering market expansion. Though international organizations are supplying millions of volume doses around the globe, many parts are yet to receive vaccination due to their high cost.
  • Infrastructure Challenges: The supply chain of vaccines requires strict temperature control to maintain their potency. In regions with inadequate cold chain infrastructure, such as rural or remote areas, this becomes challenging, potentially compromising vaccine effectiveness and decreasing demand for vaccine delivery devices.
  • Healthcare Workforce Capacity Challenges: A shortage of trained healthcare workers is hindering the proper administration of vaccines, leading to delays, dosage errors, and improper handling of delivery devices, affecting overall immunization outcomes, even with adequate delivery devices available.
  • Disruptions in the Vaccine Supply Chain: Supply chain disruption such as manufacturing delays, distribution bottlenecks, and logistics challenges, is likely to impact the availability and accessibility of vaccine delivery devices. Supply chain disruptions, whether due to natural disasters, geopolitical tensions, or public health emergencies, may disrupt immunization programs and limit the deployment of vaccine delivery devices.

Key Trends:

  • Painless Administration: There is growing interest in developing painless vaccine delivery methods to enhance patient comfort and acceptance. Technologies such as microneedle patches, which deliver vaccines through painless, minimally invasive skin punctures, offer potential advantages over traditional needle-based injections, particularly for pediatric and geriatric populations.
  • Smart Injection Devices: Integration of digital health technologies into vaccine delivery devices, such as smart injection devices equipped with sensors and connectivity features, allows for real-time monitoring of vaccination administration, dosage tracking, and adherence to vaccination schedules. These devices facilitate data collection, enhance patient engagement, and support remote patient monitoring.
  • Biodegradable and Eco-Friendly Materials: Increasing emphasis on sustainability and environmental responsibility drives the adoption of biodegradable and eco-friendly materials in vaccine delivery devices. Manufacturers are exploring alternatives to conventional plastics, such as bioplastics and compostable materials, to reduce environmental impact and promote circular economy principles.

Global Vaccine Delivery Devices Market Regional Analysis

Here is a more detailed regional analysis of the global Vaccine Delivery Devices Market:

North America:

  • North America has established regulatory frameworks for healthcare products, including vaccine delivery devices, overseen by agencies like the FDA and Health Canada. These standards ensure safety, efficacy, and quality, boosting consumer confidence and market growth.
  • The region is at the forefront of technological innovation in healthcare, including vaccine delivery devices. Advancements such as needle-free injectors, auto-disable syringes, and smart injection devices improve vaccine administration, enhance patient comfort, and optimize immunization outcomes.
  • North America is home to several key market players, including pharmaceutical companies, medical device manufacturers, and healthcare technology firms. These companies drive innovation, research, and development in vaccine delivery devices, introducing new products and technologies to the market.

Europe:

  • Europe places a strong emphasis on healthcare quality and safety, driving the adoption of advanced healthcare technologies and best practices. Vaccine delivery devices must meet high standards of safety, reliability, and performance to ensure patient well-being and public health outcomes.
  • European governments provide support for vaccination programs through funding, policy development, and public health campaigns. National vaccination schedules, recommendations, and incentives encourage vaccination uptake and drive demand for vaccine delivery devices across healthcare settings.
  • European countries continue to invest in healthcare infrastructure, research and development, and innovation to improve healthcare delivery and patient outcomes. Investments in vaccination programs, including the procurement of vaccine delivery devices, contribute to market growth and innovation in the region.

Asia Pacific:

  • Asia Pacific is home to some of the world's most populous countries, including China and India. The sheer size of the population creates a substantial demand for vaccines and vaccine delivery devices to address healthcare needs.
  • Economic growth in many countries across the Asia Pacific region has led to increased healthcare spending. Governments and private sectors are investing more in healthcare infrastructure, including vaccination programs and the procurement of vaccine delivery devices.
  • There is a growing awareness among individuals and communities in the Asia Pacific about the importance of preventive healthcare measures, including vaccination. Public health campaigns, educational initiatives, and advocacy efforts contribute to increased vaccination uptake and demand for vaccine-delivery devices.
  • Emerging economies in Asia Pacific, such as China, India, Indonesia, and Vietnam, offer significant growth opportunities due to their large populations and increasing investments in healthcare infrastructure. These countries are witnessing rapid urbanization, economic development, and healthcare reforms, driving demand for healthcare products and services, including vaccine delivery devices.

Global Vaccine Delivery Devices Market: Segmentation Analysis

The Global Medical Sensors Market is Segmented on the basis of Devices, Route Of Administration, End-User, And Geography.

Vaccine Delivery Devices Market, By Devices

  • Syringes
  • Jet Injectors

Based on Devices, The market is segmented into Syringes and Jet Injectors. Among these, syringes are expected to dominate the market as they provide flexibility in administering various vaccinations, including liquid and lyophilized vaccines (which are freeze-dried and need to be reconstituted before use). Syringes can be used in various immunization situations. However, the jet injectors segment of the Vaccine Delivery Devices Market is expanding at the quickest rate.

Vaccine Delivery Devices Market, By Route Of Administration

  • Intradermal Vaccination
  • Intramuscular Vaccination
  • Subcutaneous Vaccination

Based on Route Of Administration, The market is segmented into Intradermal, Intramuscular, and Subcutaneous. The largest market segment is intradermal, which enhances immunogenicity by interacting directly with skin-derived immune cells. Intramuscular, the most rapidly growing segment, is recommended for administering a wide range of vaccinations, booster shots, and routine immunizations to individuals of all ages due to its versatility.

Vaccine Delivery Devices Market, By End-User

  • Hospitals & Clinics
  • Home Care Settings
  • Ambulatory Surgery Centers

Based on End-User, The market is segmented into Hospitals & clinics, Home Care Settings, and Ambulatory Surgery Centers. Hospitals typically account for the majority share in the end-user segment of the Vaccine Delivery Devices Market. Hospitals often serve as centralized hubs for vaccination services, providing a wide range of vaccines to patients across various age groups and medical conditions. Academic medical centers and research hospitals play a key role in vaccine research, clinical trials, and medical education. They utilize vaccine delivery devices for research purposes, vaccine trials, and training healthcare professionals.

Key Players

The "Global Vaccine Delivery Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are 3M, Becton Dickinson & Company, Gerresheimer AG, Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.), SCHOTT AG, Valeritas, PharmaJet, Vaxxas, and Corium International, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

  • Vaccine Delivery Devices Market, Recent Developments
  • In March 2022, The National Institute of Allergy and Infectious Diseases (NIAID) initiated a clinical trial to evaluate three experimental HIV vaccines. These vaccines are developed using a messenger RNA (mRNA) platform, which has been previously used in multiple Covid-19 vaccines that have been approved.
  • In April 2023, the FDA approved CSL's immunoglobulin pre-filled syringe, Hizentra, for use in treating patients with chronic inflammatory demyelinating conditions. Primary Immunodeficiency (PI) and Polyneuropathy (CIDP). The injection offers convenient drug delivery and is ready for use.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL VACCINE DELIVERY DEVICES MARKET

  • 1.1 Introduction of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL VACCINE DELIVERY DEVICES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL VACCINE DELIVERY DEVICES MARKET, BY DEVICES

  • 5.1 Overview
  • 5.2 Syringes
  • 5.3 Jet Injectors

6 GLOBAL VACCINE DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION

  • 6.1 Overview
  • 6.2 Intradermal Vaccination
  • 6.3 Intramuscular Vaccination
  • 6.4 Subcutaneous Vaccination

7 GLOBAL VACCINE DELIVERY DEVICES MARKET, BY END-USER

  • 7.1 Overview
  • 7.2 Hospitals & Clinics
  • 7.3 Home Care Settings
  • 7.4 Ambulatory Surgery Centers

8 GLOBAL VACCINE DELIVERY DEVICES MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East and Africa

9 GLOBAL VACCINE DELIVERY DEVICES MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 3M
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Becton Dickinson & Company
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Gerresheimer AG
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 SCHOTT AG
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Valeritas
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 PharmaJet
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Vaxxas
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Corium International, Inc
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments

11 Appendix

  • 11.1 Related Research